Clinical Trial Update: Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial in Chinese patients with Acute Coronary Syndrome evaluating genotype-guided selection of oral P2Y12 inhibitors versus conventional therapy; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Brilinta (ticagrelor) (ticagrelor)
• Effient (prasugrel) (prasugrel)
• Plavix (clopidogrel) (clopidogrel)

Snippet

Sponsor: The University of Hong Kong | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED